公开(公告)号：WO2022250499A1

公开(公告)日：2022-12-01

申请号：PCT/KR2022/007581

申请日：2022-05-27

Applicant: SK BIOPHARMACEUTICALS CO., LTD.

Inventor： PENDSE, Pravada ,  BOMMANA, Murali M ,  NOH, Regina H. ,  PEGAN, Augustin ,  WEBB, Travis John ,  MAXWELL, Jejuan

IPC: A61K9/08 ,  A61K9/10 ,  A61K47/10 ,  A61K47/02 ,  A61K47/36 ,  A61K47/38 ,  A61K9/00 ,  A61K31/41 ,  A61P25/00

Abstract: The present disclosure relates to an aqueous formulation comprising as an active ingredient a carbamate compound of Formula 1, or a pharmaceutically acceptable salt, solvate or hydrate thereof, poloxamer, and an aqueous carrier, wherein the aqueous formulation is in the form of a suspension formulation.